*University of Kansas Medical Center, Kansas City, KS; †NeuroHealth, Warwick, RI; ‡University of California, Irvine, CA; §Parkinson's Disease and Movement Disorder Center of Boca Raton, Boca Raton, FL; ∥University of South Florida, Tampa, FL; ¶Harvard Vanguard Medical Associates, Boston, MA; #Coastal Neurological Medical Group, La Jolla, CA; **The Parkinson's Institute, Sunnyvale, CA; ††University of Toledo, Toledo, OH; ‡‡Struthers Parkinson's Center, Golden Valley, MN; §§Methodist Plaza Specialty Clinic, Des Moines, IA; and ∥∥University of Southern California, Los Angeles, CA.
Address correspondence and reprint requests to Kelly E. Lyons, PhD, Department of Neurology, University of Kansas Medical Center, 3599 Rainbow Blvd, Mail Stop 2012, Kansas City, KS 66160; E-mail: [email protected]
This study was supported by Valeant Pharmaceuticals.
Disclosures: Kelly E. Lyons has received honoraria or consulting fees from Advanced Neuromodulation Systems, GlaxoSmithKline, Medtronic, Novartis, Teva Neuroscience, UCB/Schwarz Pharma, and Valeant.
Joseph H. Friedman has received honoraria for lectures, funds for research or consulting from Acadia, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Neurogen, Novartis, Teva Neuroscience, Sepracor, Solvay, and UCB/Schwarz Pharma.
Neal Hermanowicz has received honoraria, consulting fees, educational grants, or research support from Allergan, Boehringer Ingelheim, GlaxoSmithKline, Kyowa, Medtronic, Merz, Novartis, Teva, Pfizer, UCB/Schwarz Pharma, and Valeant.
Stuart H. Isaacson has received honoraria, research grants, and/or consulting fees from Allergan, Boehringer Ingelheim, GlaxoSmithKline, Merz, Novartis, Ortho McNeil, Pfizer, Santhera, Schering-Plough, Solstice Neurosciences, Solvay, Teva Neuroscience, UCB/Schwarz Pharma, Valeant, and Vernalis.
Robert A. Hauser has received honoraria or consulting fees from Allergan, Bayer Schering Pharma AG, Bertek, Boehringer Ingelheim, Biovail, Centopharm, Cephalon, CombinatoRx, Daiichi, Eisai Ltd, Elan, EMD Serono, GE Healthcare, Genzyme, GlaxoSmithKline, Impax, Kyowa, Merck KGaA, Merz, Novartis, Ortho McNeil, Ovation, Penwest, Pfizer, Pharmacia, Prestwick, Schwarz Pharma, Schering, Skye Pharma, Solstice Neurosciences, Solvay, Synosia, Teva Neuroscience, UCB, United BioSource, Upsher-Smith Laboratories, Valeant, and XenoPort.
Bonnie P. Hersh has received honoraria or consulting fees from Allergan, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Teva Neuroscience and Valeant. She has received research support from Acadia, Eisai Ltd, GlaxoSmithKline, Skye Pharma, Solvay, and Valeant.
Dee E. Silver has received honoraria or consulting fees from Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Kyowa, Novartis, Pfizer, Schwarz Pharma, Teva Neuroscience, and Vernalis (Ipsen).
James W. Tetrud has received honoraria or consulting fees from GlaxoSmithKline, Schwarz Pharma, Teva Neuroscience, and Valeant.
Lawrence W. Elmer has received honoraria, consulting fees, educational grants, or research support from Boehringer Ingelheim, GlaxoSmithKline, Novartis, Teva Neuroscience, UCB, and Valeant.
Sotirios A. Parashos has received honoraria from McMahon Publishing and research support from Eisai Ltd., Kyowa, Merck KGaA, Novartis, Ovation, Schwarz Pharma, Teva Neuroscience, UCB, and Valeant.
Lynn K. Struck has received honoraria or consulting fees from GlaxoSmithKline, Kyowa, Merz, Novartis, Teva Neuroscience, UCB/Schwarz Pharma, Valeant, and Vernalis.
Mark F. Lew has received honoraria or consulting fees from Allergan, Boehringer Ingelheim, GlaxoSmithKline, Ipsen, Novartis, Prestwick, Solstice Neurosciences, Solvay, Teva Neuroscience, Valeant, and Vernalis.
Rajesh Pahwa has received honoraria or consulting fees from Boehringer Ingelheim, GlaxoSmithKline, Impax, Medtronic, Novartis, UCB, Teva Neuroscience, and Valeant.
